Dr. Eric Bernicker, MD
Claim this profileHouston Methodist Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
9 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Eric Bernicker, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Eric Bernicker, MD
Clinical Trial Related10 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Eric Bernicker, MD has experience with
- Atezolizumab
- Interleukin-12 Gene Therapy
- Biospecimen Collection
- Crizotinib
- Pembrolizumab
- Pemetrexed Disodium
Breakdown of trials Eric Bernicker, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Bernicker, MD specialize in?
Eric Bernicker, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Eric Bernicker, MD currently recruiting for clinical trials?
Yes, Eric Bernicker, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eric Bernicker, MD has studied deeply?
Yes, Eric Bernicker, MD has studied treatments such as Atezolizumab, Interleukin-12 Gene Therapy, Biospecimen Collection.
What is the best way to schedule an appointment with Eric Bernicker, MD?
Apply for one of the trials that Eric Bernicker, MD is conducting.
What is the office address of Eric Bernicker, MD?
The office of Eric Bernicker, MD is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.